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Abstract
Staphylococcus aureus colonizes the nose, throat, skin, and gastrointestinal (GI) tract of
humans. GI carriage of S. aureus is difficult to eradicate and has been shown to facilitate the
transmission of the bacterium among individuals. Although staphylococcal colonization of
the GI tract is asymptomatic, it increases the likelihood of infection, particularly skin and soft
tissue infections caused by USA300 isolates. We established a mouse model of persistent
S. aureusGI colonization and characterized the impact of selected surface antigens on col-
onization. In competition experiments, an acapsular mutant colonized better than the paren-
tal strain Newman, whereas mutants defective in sortase A and clumping factor A showed
impaired ability to colonize the GI tract. Mutants lacking protein A, clumping factor B, poly-
N-acetyl glucosamine, or SdrCDE showed no defect in colonization. An S. aureus wall tei-
choic acid (WTA) mutant (ΔtagO) failed to colonize the mouse nose or GI tract, and the
tagO and clfAmutants showed reduced adherence in vitro to intestinal epithelial cells. The
tagOmutant was recovered in lower numbers than the wild type strain in the murine stom-
ach and duodenum 1 h after inoculation. This reduced fitness correlated with the in vitro
susceptibility of the tagOmutant to bile salts, proteases, and a gut-associated defensin.
Newman ΔtagO showed enhanced susceptibility to autolysis, and an autolysin (atl) tagO
double mutant abrogated this phenotype. However, the atl tagOmutant did not survive bet-
ter in the mouse GI tract than the tagOmutant. Our results indicate that the failure of the
tagOmutant to colonize the GI tract correlates with its poor adherence and susceptibility to
bactericidal factors within the mouse gut, but not to enhanced activity of its major autolysin.
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Author Summary
Staphylococcus aureus persistently colonizes ~20% of the human population, and 40–60%
of humans are intermittently colonized by this bacterium. The most common reservoir for
S. aureus is the anterior nares, and the incidence of staphylococcal disease in higher in
individuals who are colonized. Rectal colonization by S. aureus isolates, reflecting gastroin-
testinal (GI) carriage, has recently been recognized as an important reservoir from which
person to person transmission occurs. We developed a murine model of S. aureus GI colo-
nization to investigate bacterial factors that promote staphylococcal colonization of the
gut. We identified several surface-associated S. aureus antigens that modulate colonization
of the GI tract and identified a surface glycopolymer (cell wall teichoic acid) as critical for
the early steps in colonization. The failure of the teichoic acid mutant to colonize the GI
tract can be attributed to its defects in bacterial adherence and to its enhanced susceptibil-
ity to mammalian host defenses unique to the gastrointestinal tract. Efforts to develop
antimicrobials that target WTA may lead to an overall reduction in asymptomatic coloni-
zation by antibiotic-resistant S. aureus and may impact the incidence of invasive disease.
Introduction
Staphylococcus aureus is a bacterial pathogen that commonly colonizes the nose, skin, and
mucosal surfaces of healthy individuals. However, S. aureusmay also cause a variety of superfi-
cial and invasive infections in hospitalized patients, as well as in individuals within the commu-
nity who lack the risk factors commonly associated with nosocomial infections [1,2]. Although
the anterior nares are the most common anatomic site of S. aureus carriage, ~20% of adults are
positive for intestinal carriage of S. aureus [3]. The gastrointestinal (GI) tract has been shown
to be a potentially important reservoir for S. aureus in several clinical studies [4–6]. Although
nasal carriage apparently predisposes the host to intestinal carriage, ~37% of intestinal carriers
are not positive for S. aureus nasal colonization [3]. Compared to nasal colonization only,
simultaneous nasal and intestinal colonization was associated with a significant increase in the
frequency of positive skin cultures [7]. Squier et al. [8] observed that critically ill patients who
had both rectal and nasal carriage were significantly more likely to develop staphylococcal
infection (40% infection rate) than those with nasal carriage only (18% infection rate).
Patients positive for staphylococcal GI colonization often contaminate their environment
with S. aureus [3,9]. Thus, intestinal carriage may serve as an important reservoir for S. aureus
transmission, contributing to bacterial dissemination and subsequent risk of infection [3].
Faden et al. compared methicillin-resistant S. aureus (MRSA) nasal and rectal colonization
rates in children with staphylococcal skin abscesses and a control group of children without
staphylococcal disease [10]. Whereas rates of nasal colonization were equivalent for both
groups of children, MRSA was detected significantly more often in the rectum of children with
skin abscesses (47%) compared with controls (1%). Moreover, S. aureus recovered from the
abscesses and rectum were identical in 88% of cases, compared with 75% of nasal isolates.
Almost all abscess isolates (57/60) were USA300 strains, whereas only 2 of 22 isolates from the
control groups were USA300. In a study of HIV-infected men who have sex with men, Szu-
mowski et al. reported that perianal (but not nasal) colonization by MRSA was significantly
associated with skin abscess formation [11]. These studies suggest that rectal colonization by
S. aureus, probably reflecting gastrointestinal carriage, is an important reservoir from which
person to person transmission occurs.
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Host factors that facilitate staphylococcal colonization of the GI tract are poorly understood.
Intestinal carriage occurs at a high frequency within the first six months of life, after which the
incidence drops [3]. Additional factors, such as decreased stomach acidity, antibiotics that dis-
rupt the indigenous microbiota, or the administration of cyclophosphamide or prednisone,
may also influence acquisition of S. aureus in the human GI tract [4–6].
Whereas staphylococcal factors that promote GI colonization have not been reported, sev-
eral independent investigations have identified surface antigens that impact S. aureus nasal col-
onization in rodent models. Mutants deficient in either clumping factor B or cell wall teichoic
acid (WTA) showed reduced nasal carriage in experimentally inoculated rats or mice [12,13],
and clumping factor B promoted nasal colonization of humans [14].
In this investigation, we sought to develop and characterize a reliable murine model of S.
aureus GI carriage to better understand its relevance as a risk factor for subsequent infection
and its potential for transmission and spread of this pathogen. S. aureus antigens important for
nasal colonization were assessed to determine whether they might also play a role in coloniza-
tion of the GI tract. We identified several surface-associated S. aureus antigens that modulated
colonization of the GI tract and identified WTA as critical for the early steps in colonization.
The failure of the WTA mutant (ΔtagO) to colonize the GI tract correlated with its defects in
bacterial adherence and greater susceptibility to antimicrobial factors within the mouse gut.
Results
Establishment of an S. aureus gastrointestinal colonization model in
mice
The mouse intestinal tract is comprised of diverse commensal bacteria, including Bacteroides,
Clostridia, segmented filamentous bacteria, members of the Enterobacteriaceae, Lactobacilli,
and Enterococci [15,16]. These normal flora provide some protection against invading patho-
gens, as evidenced by the fact that we were unable to establish stable ( 1 week) GI coloniza-
tion by S. aureus in conventional mice in the absence of selective antibiotic pressure (S1 Fig).
In previous studies, we maintained stable nasal colonization of mice with S. aureus by supple-
menting their drinking water with streptomycin (Sm) and inoculating with Sm-resistant (Smr)
staphylococcal isolates [12,17], and a similar approach was taken here. Fecal cultures per-
formed on mice prior to inoculation were negative for Smr S. aureus (lower limit of detection
~3 log CFU S. aureus/g stool). Awake mice maintained on Sm water and administered intrana-
sal inocula of Smr S. aureus Newman ranging from 8 x 108 to 2 x 105 CFU showed stable colo-
nization of the GI tract for at least 3 wks (Table 1). Recovery of Smr S. aureus Newman from
the stool cultures consistently averaged ~105 CFU/g stool. Differences in GI colonization of
the WT strain were not observed when we compared inoculation by the intranasal route with
inoculation by oral gavage. A subset of animals were given Sm water during week 1 and then
given regular drinking water thereafter. These mice maintained GI colonization for at least
3 weeks at levels (~105 CFU/g stool) similar to those of mice maintained for 3 wks on Sm water
(S1 Fig).
To determine where S. aureus resided in the GI tract of conventional mice, we inoculated
animals with ~109 CFU of S. aureus, and euthanized the animals on days 1, 2, 4 and 7. Seg-
ments of the GI tract were removed and cultured quantitatively. The colonized staphylococcal
density in the conventional mice was quite variable in the small intestine with the highest being
observed in the distal segment of the small intestine (1.3 x 105 CFU/g tissue), cecum (3.9 x 105
CFU/g tissue) and colon (3.2 x 105 CFU/g).
To measure the impact of the commensal GI flora on S. aureus colonization, germfree Swiss
Webster mice (n = 8) were inoculated with ~109 CFU of S. aureus, and quantitative stool
Gastrointestinal Colonization by S. aureus
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cultures were performed on days 1, 5, 7, 12, and 14. In contrast to conventional mice, germfree
mice were readily colonized by S. aureus as early as day 1 without the need for Sm drinking
water. Quantitative cultures yielded concentrations ranging from 1 x 107 to 9.7 x 108 CFU/g
stool over the course of the two-week time period. Four to five mice were euthanized on day 7
or 14, and segments of the GI tract were removed, homogenized, and cultured quantitatively.
Whereas S. aureus was detected throughout the GI tract at concentrations>104 cfu/g, signifi-
cantly higher staphylococcal densities were achieved in the distal portions of the GI tract
(Table 2). These findings corroborated those that we found in conventional mice, i.e., the high-
est bacterial burdens were localized to the mouse cecum and colon.
Bacterial factors that promote colonization of the GI tract
Previous studies revealed that S. aureusmutants deficient in sortase (ΔsrtA; affects all cell wall
anchored proteins), clumping factor B, the serotype 5 capsule, and WTA were defective in
their ability to colonize the nasal cavity of rodents [12,13,17,18]. Evaluation of microbial fitness
for colonization of the GI tract is often performed in the context of competition experiments
[19–21]. When we evaluated the relative fitness of S. aureusmutants vs. the parental strain, we
Table 1. Quantitative stool cultures frommice (n = 4–15 per group) that were inoculated with Smr S. aureus strain Newman on day zero.
Inoculum (CFU/mouse) Log CFU S. aureus Newman/g stool ± SEM at indicated time point a
Pre-inoculation Day 7 Day 14 Day 21
8.2 x 108 <3.0 5.63 ± 0.11 5.10 ± 0.36 5.67 ± 0.27
2.7 x 108 <3.0 5.26 ± 0.20 5.16 ± 0.23 5.15 ± 0.24
1.9 x 107 <3.0 5.57 ± 0.21 4.59 ± 0 62 5.89 ± 0.27
1.9 x 105 <3.0 5.86 ± 0.19 4.68 ± 0.41 5.11 ± 0.37
1.9 x 103 <3.0 3.86 ± 0.46 4.00 ± 0.33 4.00 ± 0.49
a The lower limit of detection by culture is ~3.0 log CFU S. aureus/g stool.
doi:10.1371/journal.ppat.1005061.t001
Table 2. Quantitative cultures of GI segments from germ-free mice inoculated with S. aureus and eval-
uated on days 7 or 14.
Sample S. aureus Log CFU/g sample ± SEM
Day 7 a Day 14 b
Duodenum 6.20 ± 0.71 c 6.35 ± 0.21 d
Jejunum 6.17 ± 0.43 c 6.65 ± 0.25 d
Ileum 7.41 ± 0.07 7.09 ± 0.21 e
Cecum 7.65 ± 0.09 8.26 ± 0.09
Colon 8.26 ± 0.07 8.73 ± 0.09
Stool 8.03 ± 0.11 8.56 ± 0.05
a P = 0.0024 by one-way ANOVA.
b P < 0.0001 by one-way ANOVA.
c On day 7, the S. aureus counts in the duodenum and jejunum were signiﬁcantly less than those in the
ileum (*), cecum (*), and colon (***).
d On day 14, the counts in the duodenum were signiﬁcantly less than those in the ileum (**), and the
counts in the duodenum and the jejunum were less than those in the cecum (****), and colon (****).
e On day 14, the counts in the ileum were less than those in the cecum (***) and colon (****).
*, P <0.05; **, P <0.01, ***, P <0.001, ****, P <0.0001.
doi:10.1371/journal.ppat.1005061.t002
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observed that the acapsular Newman cap5Gmutant showed enhanced fitness, colonizing the
mouse GI tract in numbers greater than that of the parental type 5 capsule positive strain (Fig
1). The sortase A mutant and a clumping factor A (clfA) mutant showed impaired fitness in
vivo, since both were out-competed by the wild type (WT) strain Newman (Fig 1). To validate
the latter finding, we repeated the competition experiment between strain Newman and its clfA
mutant with inoculation by oral gavage. Similar to our initial findings, the clfAmutant again
showed a significant colonization defect between 7 and 21 days after inoculation (S2 Fig).
Newman Δica, Newman ΔclfB, Newman Δspa, and Newman ΔsdrCDE showed no colonization
defect (S3 Fig).
When we inoculated separate groups of 5 to 10 mice with the parental strain Newman or
isogenic mutants lacking the serotype 5 capsule, sortase, or ClfA, we observed no differences
between the colonization levels achieved by the parental or mutant strains (S4 Fig). Thus, the
colonization defects of these three mutants were only evident as measured by in vivo competi-
tion experiments. Likewise, a mutant defective in beta hemolysin (Hlb) colonized the mouse
gut at levels consistent with the respective parental strains (S4 Fig).
Weidenmaier et al. reported that a tagOmutant failed to colonize the nasal cavity of cotton
rats [13]. To elucidate the role of WTA in GI colonization, separate groups of mice were inocu-
lated with S. aureus SA113 or Newman or their isogenic tagO or dltAmutants. Both SA113
ΔtagO and Newman ΔtagO showed a significant (P<0.01) reduction in GI colonization as
early as one week after intranasal inoculation compared to the parental strain (Fig 2A), despite
the fact that the growth of the mutant in vitro was comparable to that of the parental strain
[22]. To confirm these findings, additional groups of mice were inoculated by oral gavage with
strain Newman or its tagOmutant, and GI colonization was monitored up to 72 h. By 24 h
after inoculation, there were significantly fewer Newman ΔtagO recovered from the stools of
mice inoculated with Newman ΔtagO compared to the WT strain (S5 Fig). These data suggest
that the WTA polymer is a critical determinant for colonization of the GI tract by S. aureus. To
determine whether modifications of the WTA backbone affect GI colonization, we inoculated
mice with dltAmutants of strain SA113 or Newman, which lack the ester-linked alanine sub-
stituent on staphylococcal teichoic acid. The dltAmutants showed no colonization defect
(Fig 2A). Similarly, a ΔtarM ΔtarS double mutant of S. aureus RN4220, which lacks alpha- and
beta-O-linked GlcNAc modifications of WTA, colonized mice at levels similar to theWT strain
(S6 Fig).
WTA has been reported to promote staphylococcal adherence to human nasal epithelial
cells and endothelial cells [13,23]. As a result, we compared the relative in vitro adherence of
strains Newman and Newman ΔtagO to T84 human intestinal epithelial cells. As shown in
Fig 2B and 2C, strain Newman showed significantly (P = 0.0009) greater adherence to the T84
cells than did its ΔtagOmutant. Likewise, the clfAmutant, which showed an in vivo fitness
defect (Fig 1C), also showed impaired adherence to T84 cells (Fig 2B and 2C; P = 0031). The
acapsular cap5Gmutant, on the other hand, showed a modest increase in overall adherence to
the epithelial cells, consistent with previous studies showing that the capsule can mask adhesins
that mediate attachment to mammalian cells [24,25].
Competition between Newman and Newman ΔtagO within the GI tract
To determine whether a WTA-deficient mutant was competent for transit through the stom-
ach and duodenum to establish a colonization niche in the intestines, we performed several
short-term in vivo experiments. Mice were inoculated with either strain Newman or the New-
man tagOmutant and euthanized after 1 h. Recovery of S. aureus by quantitative cultures of
the stomach and four different segments of the GI tract were quite variable among different
Gastrointestinal Colonization by S. aureus
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Fig 1. S. aureus factors that impact colonization of the murine GI tract. A) The Newman serotype 5
capsule-negative mutant showed a competitive fitness advantage relative to the wild type Newman capsule-
positive strain.B) A sortase A mutant andC) a clumping factor A (ClfA) mutant showed a competitive defect
compared to the parental strain Newman. The competitive index (CI) was defined as the log10 output ratio/
input ratio. A CI <0 indicates a mutant with a colonization advantage over theWT strain, and a CI >0 indicates
a mutant with a colonization disadvantage compared to the WT. Horizontal bars represent the median
competitive index for groups of 5–15 mice. P-values were determined byWilcoxon signed-rank test.
*P < 0.05; ** P < 0.01; *** P < 0.001.
doi:10.1371/journal.ppat.1005061.g001
Gastrointestinal Colonization by S. aureus
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mice. For this reason, we performed subsequent experiments in a competition format wherein
mice were inoculated with a 1:1 mixture of Newman and Newman ΔtagO. A control in vitro
competition experiment whereby Newman and its tagOmutant were cultured together for 1 h
showed a CI of 0. Strain Newman and its tagO isogenic mutant were co-inoculated into mice,
and after 1 h segments of the gut were homogenized and cultured quantitatively. The Newman
ΔtagOmutant exhibited a substantial fitness defect in vivo with median CIs of 0.33 and 0.92 in
the murine stomach and duodenum, respectively (P< 0.05) (Fig 3A). Few S. aureus colonies
were recovered from the fourth segment of the small intestine, the cecum, or the colon, and
consequently these data were not analyzed further. Our findings indicate that the ΔtagO
mutant is significantly impaired in surviving transit through the mouse stomach and duode-
num, and that its failure to colonize the GI tract may reflect its inherent susceptibility to anti-
microbial factors in the gut.
Relative susceptibility of the ΔtagOmutant to antibacterial factors in the
mouse GI tract
Because the tagOmutant survived poorly in vivo after inoculation, we hypothesized that New-
man ΔtagOmight be more susceptible than the WT strain to bile salts or low pH. As shown in
Fig 3B, the tagOmutant was more susceptible than strain Newman to killing by bile salts
Fig 2. Effects of WTA on S. aureusGI colonization and the influence of surface antigens on in vitro adherence of S. aureus to T84 cells. A) Fecal
cultures were performed 7 d after bacterial inoculation with 109 CFU S. aureus. Each dot indicates the CFU S. aureus/g stool for a single mouse, and the
median of each group of animals is indicated by a horizontal line. The lower limit of detection by culture was ~2.5 log CFU/g stool. P-values were determined
by Kruskal-Wallis test with Dunn’s multiple comparison test.B) At an MOI of 100, Newman ΔtagO and ΔclfAwere less adherent in vitro to T84 intestinal
epithelial cells than WT strain Newman, as measured by the number of adherent S. aureus per field of view (FOV). * P < 0.05; ** P < 0.01; *** P < 0.001.C)
The relative adherence of strain Newman and its isogenic mutants lacking WTA (ΔtagO), ClfA, or capsular polysaccharide (Δcap5G) to T84 cells in vitro was
viewed by confocal microscopy. Immunostaining was performed with mouse anti-ZO-1 (red) to visualize the T-84 apical tight junctions and S. aureus rabbit
antiserum to identify the bacteria (green). Scale bar, 10 microns.
doi:10.1371/journal.ppat.1005061.g002
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(0.075% sodium deoxycholate), and the killing was rapid (~1 h). Because the concentration of
bile salts in hepatic bile can reach concentrations as high as 1.66% [26], the enhanced suscepti-
bility of the tagOmutant may contribute to its poor recovery from the gut after only 1 h in
vivo. In contrast, both the parental and mutant strains were killed under low pH conditions
(glycine buffer, pH 3.0–3.6), and no differences in their relative susceptibilities to acidic condi-
tions were observed (S7 Fig).
The antimicrobial peptide α-defensin 5, secreted by mammalian Paneth cells, plays a role in
the intestinal host defense against bacterial pathogens. Furthermore, α-defensins demonstrate
homeostatic control of the host commensal microbiota [27]. Our in vitro studies indicated that
the Newman ΔtagOmutant was killed to a significantly greater extent than the WT strain after
a 2 h exposure to α-defensin 5 concentrations ranging from 5–10 μM (Fig 3C), which are far
below the 14–70 μM concentrations found in the human intestinal lumen [28].
Bacteria transiting the GI tract are also exposed to proteolytic enzymes. Although we
could not demonstrate consistent differences in susceptibility during short-term exposures to
Fig 3. The reducedGI fitness of theΔtagOmutant correlates with its susceptibility to bile, defensins,
and proteases. A)Mice were inoculated with a 1:1 mixture of theWT and ΔtagOmutant. After 1 h segments of
the gut were homogenized and cultured quantitatively. The average S. aureus bacterial burden in the stomach
was 3.2 x 106 CFU/g, and the first three segments of the small intestine yielded S. aureus concentrations of
2.6 x 105, 5.3 x 105 and 3.4 x 107 CFU/g, respectively. Horizontal bars represent the median competitive index
for groups of 9–10mice. P values were determined byWilcoxon signed-rank test.B) S. aureus suspensions
were exposed in vitro to bile salts (0.075% sodium deoxycholate), and quantitative cultures were performed to
evaluate bacterial survival compared with samples lacking deoxycholate. Data are representative of 3
separate determinations.C) S. aureuswere exposed for 2 h to increasing concentrations of α-defensin 5. The
data are means ± SEM of 3 experiments.D) S. aureus at 1 x 106 CFU/ml were incubated at 37°C in the
presence of increasing concentrations of proteinase K, and bacterial viability was measured after 24 h. The
data are means ± SEM of 3 independent experiments. P-values were determined by the Student t-test.
*P < 0.05, **P < 0.01, ***P < 0.001.
doi:10.1371/journal.ppat.1005061.g003
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proteases (S8 Fig), the tagOmutant was more sensitive than the parental strain Newman to
overnight treatments with proteinase K (Fig 3D), pepsin (at low pH) and trypsin (S8 Fig).
Bactericidal activity of staphylococcal supernatants for Newman ΔtagO
As noted above, when 109 CFU of Newman and its tagOmutant were incubated together in
vitro for 1 h at 37°C in tryptic soy broth (TSB; Difo, Sparks, MD), the competitive index was 0,
i.e., both strains were recovered in equivalent numbers. However, if the two strains were incu-
bated together overnight in TSB, the tagOmutant could not be recovered from the culture
(>107 reduction in CFU compared to strain Newman). Similar experiments performed with
WT strain SA113 and its tagOmutant yielded comparable results (~105 reduction in the
SA113 ΔtagO CFU compared with SA113). Filter-sterilized culture supernatants of S. aureus
Newman (but not culture supernatants from the tagOmutant) also showed bactericidal activity
toward Newman ΔtagO within 1 to 3 h of incubation (Fig 4A and 4B). The bactericidal activity
of the Newman culture supernatant was lost if it was boiled for 5 min prior to inoculation with
Newman ΔtagO (Fig 4A). In contrast, the addition of a protease inhibitor cocktail to the super-
natant had no effect on its killing activity (Fig 4A). Consistent with this finding, we observed
Fig 4. Culture supernatants of WT S. aureuswere bactericidal for Newman ΔtagO. A)Newman supernatants (untreated), boiled, or supplemented with
a protease inhibitor cocktail (PIC) were inoculated with Newman or Newman ΔtagO and incubated at 37°C. Bactericidal activity was measured by
quantitative cultures at the indicated time points.B) Newman culture supernatants were supplemented with 0, 2, or 4 mg peptidoglycan and inoculated with
either Newman or Newman ΔtagO. CFU/ml determinations were performed to evaluate bacterial viability. The data represent means ± SEM of 3 independent
experiments. C) Zymogram of Newman and ΔtagO culture supernatants. The samples were concentrated and adjusted to equivalent protein concentrations
before electrophoresis.D) Newmanmutants were inoculated into filter-sterilized Newman culture supernatants, and bactericidal activity was measured after
3 h. ΔtagO C’ carried pRBtagO, which restoredWTA production to the tagOmutant. E) Newman or Newman ΔtagO was added to culture supernatants of S.
aureusNewman, ΔtagO, ST80, or Sanger 252, and bactericidal activity was measured at 3 h. The data represent means ± SEM of 3–4 experiments.
doi:10.1371/journal.ppat.1005061.g004
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no differences in the protease activity of culture supernatants derived from the WT or the
ΔtagOmutant strain when measured on casein agar plates, azocasein assays, or the PDQ prote-
ase assay [Athena Environmental Sciences, Inc., Baltimore, MD] (S9 Fig). Peptidoglycan frag-
ments added to filter-sterilized culture supernatants of strain Newman inhibited killing of the
ΔtagOmutant in a dose dependent manner (Fig 4B). This finding suggested that autolysins
present in the Newman culture supernatant might be lysing the tagOmutant. Indeed, zymo-
gram analysis revealed that the Newman culture supernatant showed greater autolytic activity
than that of the tagOmutant (Fig 4C). That the bactericidal effect on the WTA mutant was
due to exogenous autolytic activity was supported by the observation that both the tagO and an
autolysin (atl) tagO double mutant showed a>2-log reduction in CFU/ml following a 3-h
exposure to the Newman culture supernatant (Fig 4D). In contrast, neither strain that pro-
duced WTA (the atlmutant nor Newman ΔtagO complemented with a plasmid carrying the
cloned tagO gene [ΔtagO C’]) were killed after incubation with the Newman supernatant. The
susceptibility of the tagOmutant to the bactericidal activity of culture supernatants was not
limited to strain Newman, since Newman ΔtagO was also killed by supernatants harvested
from S. aureus strains USA300 LAC and ST80, but not from Sanger 252 (Fig 4E). None of the
culture supernatants were bactericidal against the parental strain Newman.
Koprivnjak et al. reported that S. aureus SA113 ΔtagO was more sensitive than the WT
strain to Triton X-100 at concentrations>0.1% [29]. We observed that Newman ΔtagO also
was hypersusceptible to Triton X-100 mediated bacterial lysis at concentrations as low as
0.05% (Fig 5A). As expected, a Newman atlmutant and an atl tagO double mutant were resis-
tant to Triton X-100 induced autolysis (Fig 5A). Because factors that stimulate autolytic activ-
ity include detergents, proteolytic enzymes, and cationic peptides [30], we hypothesized that
the Newman ΔtagOmight be more sensitive than the WT strain to factors that promote staph-
ylococcal autolysis. This hypothesis is consistent with the observation made by Atilano et al
[31] that peptidoglycan prepared from a ΔtagOmutant shows reduced cross-linking compared
to the WT strain. Autolysin extracts from strain Newman and Newman ΔtagO showed similar
lytic activity toward peptidoglycan prepared from the strain Lafferty (S10 Fig). However, pep-
tidoglycan prepared from the Newman ΔtagOmutant was more susceptible to Newman auto-
lysin extracts than a peptidoglycan preparation from the parental strain Newman (Fig 5B).
GI colonization by a WTAmutant resistant to autolysis (Δatl ΔtagO). To clarify the
relationship between the defect in GI colonization of the tagOmutant and its susceptibility to
autolysis, we inoculated separate groups of mice with Newman, Newman Δatl, Newman
ΔtagO, or an atl tagO double mutant; GI colonization was assessed up to 14 days after inocula-
tion. The Newman Δatlmutant colonized the mouse GI tract as well as the WT strain, but
the ΔtagO and the Δatl ΔtagO double mutant failed to colonize (S11 Fig). When the experi-
ment was repeated, we observed that both the tagO and the atl tagO double mutant were recov-
ered in reduced numbers from the stool as early as two days after inoculation, and by day five
neither mutant could be detected in the murine stool cultures (Fig 6). Similar results were
obtained in mice inoculated by oral gavage (S5 Fig). In a competition format, four mice were
inoculated with a 1:1 mixture of Newman and the Newman double mutant and euthanized for
quantitative cultures after 1 h. Like the tagOmutant, Newman Δatl ΔtagO exhibited a substan-
tial fitness defect in vivo with a median CI of 1.9 in the stomach and CIs ranging from 0.98 to
1.6 in the proximal small intestine. These results indicate that the failure of S. aureus lacking
WTA to colonize the GI tract is not explained by its enhanced autolytic response (lacking in
the double mutant), but instead correlates with its poor adherence and susceptibility to bacteri-
cidal factors within the mouse gut.
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Discussion
In addition to its niche within the nares, in the throat, and on the skin of humans, S. aureus
may also colonize the GI tract of ~20% of otherwise healthy individuals [3]. While no disease is
clearly associated with GI colonization by staphylococci, it serves as a source of recolonization
after eradication of nasal colonization. In a hospital setting or in the community, fecal contami-
nation associated with diarrhea or incontinence could contaminate the environment and facili-
tate transmission among individuals. As such, the GI tract is an under-appreciated reservoir
for methicillin-resistant and-sensitive strains of S. aureus. Among patients in an intensive care
unit or transplant unit, those positive for both rectal and nasal carriage of S. aureus were more
likely to develop a staphylococcal infection than those with nasal carriage alone [8]. Other
reports have similarly suggested that GI carriage is an important risk factor for S. aureus infec-
tions [3,4,9,10]. Importantly, staphylococcal skin and soft tissue infections are linked to rectal,
but not nasal, colonization by MRSA strains in children [10]. Molecular typing experiments
Fig 5. The relative susceptibilities of S. aureus strains and their peptidoglycan preparations to
autolysis. A) Triton X-100 induced autolysis of S. aureusNewman, ΔtagO, Δatl, and ΔtagOΔatlmutants. The
results shown are representative of 3 independent determinations. B) An S. aureusNewman autolysin extract
(25 μg protein/ml) was prepared and incubated with peptidoglycan isolated from Newman and Newman
ΔtagO. The data represent means ± SEM of 3 independent experiments. Lysis was expressed as a
percentage of the OD580 nm at time zero.
doi:10.1371/journal.ppat.1005061.g005
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indicated that rectal, nares, and infecting isolates (including blood isolates) were clonally iden-
tical in 82% of the patients with S. aureus infections [8]. A comprehensive understanding of
the factors involved in asymptomatic carriage by S. aureus in humans is critical to our ability to
control the incidence of infection.
Kernbauer et al. [32] recently reported that mice challenged intravenously with S. aureus
develop staphylococcal colonization of the GI tract, and that fecal shedding resulted in S.
aureus transmission to cohoused naïve mice. They noted that GI colonization resulted in no
obvious signs of infectious abscesses or inflammation. In our studies, healthy mice inoculated
intranasally developed persistent S. aureus GI colonization only when they were administered
Sm in their drinking water for at least one week. This suggests that transient suppression of the
indigenous intestinal flora may reduce bacterial interference and created an environment ame-
nable to stable S. aureus colonization. The concentration of S. aureus in the cecum, colon, and
stool was not high in conventional mice, achieving levels ~105 CFU/g, very similar to those
reported by Kernbauer et al. [32]. When germ-free mice that lacked a competing indigenous
flora were inoculated with S. aureus, the concentrations in the intestinal contents and stool
rose to ~108 CFU/g.
To investigate bacterial factors that impact GI colonization, we assessed colonization of
mice inoculated with a single bacterial strain, and we also performed competition experiments
between WT and mutant S. aureus strains. A Newman type 5 capsule-negative mutant was
able to persist in the gut in higher numbers than the WT encapsulated parental strain in com-
petition experiments, consistent with previous studies showing that the capsule can impede
factors critical for colonization [24,25]. The Newman sortase and clfAmutants each showed
impaired fitness in the mouse gut. In contrast, strains with mutations in clfB, spa, sdrCDE, or
the ica locus showed no fitness defect in the GI colonization model. This suggests that ClfA
and perhaps other wall-anchored protein adhesins (possibly masked by the capsule) play a role
in promoting S. aureus colonization of the GI tract. Competition experiments are commonly
used to assess microbial fitness for colonization of the GI tract [19–21], probably because they
are more sensitive and may reveal more subtle competitive advantages demonstrated by a par-
ticular wild type or mutant strain.
Fig 6. Both NewmanΔtagO and Newman Δatl ΔtagO fail to persistently colonize the mouse GI tract.
Mice were inoculated on day 0 with Newman, Newman ΔtagO, or Newman Δatl ΔtagO, and stool samples
were cultured quantitatively 1, 2, 5, and 7 days after inoculation. Each symbol represents a stool culture from
an individual mouse. P values were determined byWilcoxon signed-rank test. **P < 0.01.
doi:10.1371/journal.ppat.1005061.g006
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More striking, however, was our observation that tagOmutants of strains SA113 and New-
man that fail to produce WTA were unable to colonize the nose or the GI tract of mice. This
colonization defect was evident in groups of conventional mice inoculated with pure cultures
of the mutant strain; competition assays were not necessary to demonstrate this impaired colo-
nization phenotype in vivo. S. aureusmutants that lacked the D-ala or GlcNAc substituents of
WTA, on the other hand, showed no defects in GI colonization. These findings suggest that the
glycopolymer itself, and not its modifying groups, are critical for interactions with the host.
In vitro assays demonstrated that both the tagO and clfAmutants of strain Newman were
less adherent to T84 cells in vitro than the parental strain Newman. These data suggest a criti-
cal role for these surface antigens in GI colonization. Baur et al. [33] recently reported that
S. aureusWTA interacts with a scavenger receptor (SREC-I; scavenger receptor expressed by
endothelial cell-I) detected on nasal epithelial cells to promote bacterial adherence. Whether
such a receptor is found on intestinal epithelial cells remains to be determined.
In addition to its adherence defects, the tagOmutant showed fitness defects in transit
through the mouse stomach and intestines. In an in vivo competition study, the tagOmutant
was outcompeted by the WT strain within 1 h after inoculation. This finding is consistent with
our in vitro observations that the tagOmutant was more susceptible than the parental strain to
bile acids, proteases, and alpha defensin 5, which would be encountered in the GI tract. Like
humans, mice have Paneth cells in the small intestinal crypts, and these cells secrete alpha
defensins that show bactericidal activity against a number of microbes, including S. aureus
[34].
S. aureus autolysins are activated by detergents (Triton X-100 and bile acids such as deoxy-
cholate), defensins, and proteases [30]. Because these factors are present in the GI tract, we pos-
tulated that the Newman tagOmutant did not survive well because it is more susceptible to
stress-induced autolysis than the wild-type strain. To address this, we created an atl deficient
mutant of strain Newman. Atl is the major S. aureus autolytic enzyme, and it binds preferen-
tially at the septum site (where WTA is less abundant) to facilitate cell division. However, Atl
loses its selective localization to division sites in a tagOmutant. In the absence of WTA, Atl
binding was reported to be evenly distributed on the cell surface, which explains the increased
fragility and susceptibility of the ΔtagOmutant to autolysis [31,35]. As expected, the atl and
the atl tagO double mutant were both resistant to Triton X-100-induced lysis (activation of
endogenous autolysins), whereas both the tagO and atl tagO double mutant were highly sus-
ceptible to exogenous autolysins (in Newman culture supernatants).
Our final in vivo colonization studies showed that the WT strain Newman and its isogenic
atl mutant were both proficient for GI colonization. However, neither the tagO nor the atl tagO
double mutant colonized the mouse gut. These results indicate that the enhanced sensitivity of
the tagOmutant to antimicrobial factors in the GI tract, as well as its poor adherence character-
istics, likely contribute to its impaired fitness in vivo. However, the enhanced vulnerability of
the tagOmutant to clearance from the GI tract is apparently not due to activation of its endoge-
nous autolysins by host-induced bacterial stress. Previous studies have characterized the in
vitro susceptibility of S. aureus ΔtagO to a variety of host immune defenses. Compared to the
parental strains, a ΔtagOmutant showed increased susceptibility to antimicrobial fatty acids on
human skin [36], but it was not more susceptible to killing by neutrophils, lysozyme [37], lacto-
ferrin, or cationic antimicrobial peptides such as hNP1-3, LL37, or magainin II amide. Mutants
lacking WTA were more resistant to mammalian group IIA phospholipase A2 and human β-
defensin 3 (HBD-3) than the WT strain [29]. Additional studies will be necessary to further
delineate the essential role of WTA in S. aureus colonization of the mammalian GI tract.
The murine colonization model may be useful in further characterization of factors that
impact S. aureus carriage in the GI tract, with the acknowledged limitation that the human
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intestinal tract and its flora have characteristics distinct from those of the mouse [38]. None-
theless, our results show that S. aureusWTA contributes to staphylococcal fitness within the
GI tract, providing resistance to host bactericidal factors and promoting bacterial adherence to
epithelial cells. A better understanding of mechanisms that lead to asymptomatic colonization
by S. aureusmay lead to preventive therapies that impact transmission among humans. Recent
efforts to develop antimicrobials that target WTA [39–41] may lead to effective agents that
diminish both nasal and GI colonization by MRSA and may impact invasive disease [23].
Materials and Methods
Bacterial strains
The S. aureus strains tested in the murine gastrointestinal colonization model are listed in
Table 3; each was resistant to Sm. Mutations in the S. aureus ica locus, spa, and atl were moved
into Sm-resistant Newman by transduction with phage 80α or phage 85 from the original
antibiotic marked mutant strains [42–44]. The tagO::tetmutation was moved from S. aureus
RN4220 into Newman Δatl as described previously [22]. Mutants were confirmed by PCR or
Southern blot analysis and were phenotypically identical to the parental strains in terms of the
growth rate, hemolysis on sheep blood agar plates, and the metabolic profile on API Staph
test strips (Biomerieux, Inc., Durham, NC). S. aureus strains were cultivated in TSB to the loga-
rithmic growth phase, unless otherwise noted. Sm (0.5 mg/ml; Sigma Chemical Co., St. Louis,
Mo.), erythromycin (Em; 5 μg/ml; Sigma), tetracycline (Tc; 2.5 μg/ml; Sigma), or spectinomy-
cin (Spc; 100 μg/ml; MP Biomedicals, Solon, OH) was added to culture medium for selection
where appropriate.
Table 3. Sm-resistant S. aureus strains used in this study.
S. aureus strain Relevant characteristics a, b Reference
Newman WT, capsule type 5 [12]
Newman Δatl Lacks the major autolysin, Emr This study
Newman ΔclfA Lacks clumping factor A; clfA1::Tn917 [52]
Newman Δcap5G Lacks type 5 capsule production, Emr [53]
Newman ΔclfB Lacks clumping factor B; Emr [12]
Newman ΔdltA Lacks teichoic acid D-alanine esters, Spcr [22]
Newman Δica Lacks poly-N-acetyl glucosamine, Tcr This study
Newman Δspa Lacks protein A [44]
Newman ΔsrtA Lacks sortase A; adhesin-deﬁcient; Emr [12]
Newman ΔtagO Lacks wall teichoic acid, Tcr [22]
Newman ΔtagO (pRBtagO) Complemented ΔtagO; restored for WTA production [22]
Newman ΔatlΔtagO Lacks autolysin and wall techoic acid; Tcr, Emr This study
NCTC 8325–4 NCTC 8325 cured of three prophages [54]
NCTC 8325–4 hlb::Φ42E NCTC 8325–4 Φ42E lysogen, beta toxin negative [55]
NCTC 8325–4 Δatl Lacks the major autolysin, Emr [43]
RN4220 ΔtarM ΔtarS Lacks β-O-GlcNAc and β-O-GlcNAc groups on WTA [56]
SA113 WT, acapsular [57]
SA113 ΔtagO Lacks wall teichoic acid, Emr [13]
SA113 ΔdltA Lacks teichoic acid D-alanine esters, Spcr [58]
a Mutant strains were derived from Sm-resistant WT strain.
b Tc, tetracycline; Spc, spectinomycin; Em, erythromycin.
doi:10.1371/journal.ppat.1005061.t003
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Ethics statement
Animal experiments were approved by the Longwood Medical Area's Institutional Animal
Care and Use Committee under protocol 86–02131. All studies were performed in strict accor-
dance with the National Institutes of Health standards as set forth in "Guide for the Care and
Use of Laboratory Animals" (DHSS Publication No. (NIH) 85–23).
Murine model of gastrointestinal colonization
Conventional female ICR mice aged 4–6 wks old were purchased from Harlan Sprague Dawley,
Inc. (Indianapolis, IN) or Charles River Laboratories (Wilmington, MA). The mice were given
drinking water containing Sm (0.5 g/L) one day prior to inoculation and for the course of
experiment (unless otherwise noted), and the drinking water and cages were changed twice a
week. Conventional mice were inoculated without prior anesthesia by the intranasal route with
10 μl of an S. aureus suspension as described [12]. Gastrointestinal colonization by S. aureus
was evaluated by quantitative cultures of representative mouse stool pellets that were collected
prior to inoculation and weekly thereafter. The samples were weighed, suspended in 2–5 ml of
TSB, diluted, and plated quantitatively on mannitol salt agar (MSA) containing 0.5 mg/ml Sm.
The plates were incubated aerobically for 48 h at 37°C, the colonies were enumerated, and the
data were expressed as CFU/g stool. Significant (P< 0.05) differences between quantitative cul-
ture results were determined by the two-tailed Student t test, and the Welch correction was
applied to pairs with unequal variances. P-values for experiments having three or more groups
were determined by the Kruskal-Wallis test with Dunn’s multiple comparison analysis (Prism;
GraphPad Software, La Jolla, CA).
Germfree Swiss-Webster female mice (3–4 weeks old) were purchased from Taconic Farms
(Hudson, NY) and maintained in a negative-pressure BL2 isolator by personnel at the gnotobi-
otic core facility of the Harvard Digestive Diseases Center. S. aureus suspensions were drawn
into a sterile syringe with a neonatal feeding tube, and ~ 200 μl (~109 CFU) was orally fed to
the mice. Gnotobiotic mice were given sterile (no Sm) drinking water, and their stools were cul-
tured on nonselective medium (tryptic soy agar [TSA] plates).
For competition experiments, the mutant and parental strains were mixed in equal numbers
(total 109 CFU/mouse) prior to inoculation of conventional mice. The input CFU ratio was cal-
culated by dividing the wild type inoculum CFU by the mutant inoculum CFU (WT/mutant).
At various time points, stool samples were collected and plated quantitatively on MSA + Sm
plates. Colonies of the mutant strains were distinguished from those of the parental strain by
transferring (via sterile toothpicks) ~100 colonies to TSA and TSA + antibiotic (Tc, Em, or
Spc) plates. The output CFU ratio was determined by dividing the WT CFU by the mutant
CFU for each fecal sample. A competitive index (CI) was calculated as described [45] by divid-
ing the output ratio by the input ratio, and the CI was expressed as log10. A CI = 0 indicates
similar numbers of CFU of the two competing strains recovered in vivo, suggesting comparable
fitness of the strains in vivo. A CI>1 indicates the fitness advantage of the parental strain over
the mutant, whereas a CI<1 indicates that the mutant is more fit than the parental strain. A
Wilcoxon signed-rank test was used to determine whether the CI values were significantly dif-
ferent from the hypothetical value of zero. For in vitro competition experiments, the parental
and mutant strains were inoculated together into 5 ml of TSB, grown with aeration for either 2
or 24 h at 37°C, and subsequently plated quantitatively. Colonies of the ΔtagOmutant were dis-
tinguished from those of the parental strain by their antibiotic resistance as described above,
and the CI was calculated.
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Competition between Newman and Newman ΔtagO in transit through
the GI tract
To determine whether the tagOmutant survived as well as the parental strain in its transit
through the mouse stomach, rodent chow was withheld for 3 h prior to inoculation of mice
with either S. aureus Newman, Newman ΔtagO, or Newman ΔtagO Δatl. The mice were eutha-
nized by CO2 asphyxiation after 1 h, and quantitative cultures were performed on homogenates
made from different segments of the GI tract. However, variations in the recovery of S. aureus
among individual mice were substantial, and we were unable to draw meaningful conclusions
from these data. To circumvent this problem, competition experiments were performed as
described above in which equal numbers (~5 x 108 CFU) of the two strains were mixed before
inoculation. One hour after bacterial challenge, the mice were euthanized, the GI tract was
excised, and the stomach, small intestine (4 segments), cecum, and colon were separated. Each
segment was weighed, homogenized in 1 ml TSB, and cultured quantitatively on MSA + Sm
plates. Colonies of the ΔtagOmutant were distinguished from those of the parental strain by
replica plating on TSA + Tc or TSA + Em, and the CI was calculated.
Adherence of Newman vs. ΔtagO to T84 cells
Polarized monolayers of human intestinal T84 cells were cultured on 0.33 cm2 polyester Trans-
well inserts (Corning, Acton, MA) as previously described [46]. Log-phase TSB cultures of S.
aureus Newman or its isogenic mutants were washed in Hanks Balanced Salt Solution (HBSS)
and incubated at a multiplicity of infection of 100 on the apical surfaces of polarized T84
monolayers for 1 h at 37°C. Inserts were washed five times with HBSS and processed for confo-
cal microscopy as previously described [47]. Briefly, the T84 cell monolayers were fixed in 4%
paraformaldehyde for 20 min. The cells were washed 3x in HBSS, permeabilized with 0.2%
Saponin/HBSS solution, washed again, and blocked with 10% normal goat serum (NGS)/HBSS
solution. Immunostaining was performed with mouse anti-ZO-1 (1:200; Invitrogen) and S.
aureus rabbit antiserum (raised to whole killed bacteria and diluted 1:400) in 10% NGS/HBSS.
The cells were incubated with AlexaFluor 568 labeled goat anti-mouse conjugate and Alexa-
Fluor 488 labeled goat anti-rabbit conjugate (both 1:400 in 10% NGS/HBSS solution; Invitro-
gen) for 1 h at room temperature. Samples were imaged by confocal microscopy on a Nikon
TE2000 inverted microscope (Nikon Instruments, Melville, NY) coupled to a Perkin-Elmer
spinning disk confocal unit (Boston, MA), using a Nikon PlanFluor 40× (1.3 NA) and Nikon
PlanApo 60x (1.4 NA) oil immersion objective lens and an Orca AG scientific-grade cooled
CCD camera (Hamamatsu Photonics K.K., Japan). Confocal images, collected en face to the
apical membrane, were 3D stacks collapsed into a single projection. Adherence was quantified
by counting the total bacteria in 20 random fields of view (FOV) among triplicate samples with
a 63X objective and a 10X ocular lens.
Bactericidal assays
NewmanWT and ΔtagO were cultivated in TSB to log phase at 37°C, washed in 10 mM phos-
phate buffer (pH 7.4), and suspended to 1–3 x 108 CFU/ml in either buffer, bile salts (sodium
deoxycholate [DOC]; Sigma), or human α-defensin 5 (HD5) (Peptide Institute, Inc., Osaka,
Japan). Susceptibility to low pH was assessed by suspending S. aureus strains in glycine buffer
(pH 3.0, 3.3, or 3.6) or in phosphate buffer at neutral pH. Bacterial suspensions were incubated
at 37°C for 1 to 2 h, and viable counts were determined. Susceptibility to proteases was assessed
by preparing serial dilutions in optimal buffers (proteinase K in 10 mM phosphate buffer, pH
7.4; pepsin in glycine buffer, pH 3.6; trypsin in 10 mM phosphate, pH 8.0 buffer). The protease
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solutions were then inoculated with logarithmic-phase S. aureus to a final concentration of 1 x
106 CFU/ml, and viability counts were performed after incubation for 24 h at 37°C.
The bactericidal activity of S. aureus culture supernatants was assessed by culturing the S.
aureus strains in TSB at 37°C for ~21 h. Filter-sterilized culture supernatants were inoculated
to a final 105 CFU/ml with strain Newman or ΔtagO, ΔtagO (pRBtagO) [22], Δatl, or Δatl
ΔtagOmutants. CFU/ml determinations were performed after incubation for 1 to 5 h at 37°C.
For some assays, the Newman supernatant was boiled for 5 min, treated with a protease
inhibitor cocktail (Sigma P-8465), or supplemented with 0 to 4 mg peptidoglycan purified
from S. aureus Lafferty [48] as described [22] before inoculation with strain Newman or its
tagOmutant.
S. aureus autolysin activity
Triton X-100-induced autolysin assays were performed as described by Shaw et al. [49]. Briefly,
NewmanWT and ΔtagO strains were grown to logarithmic phase, and the bacterial cells were
washed twice and suspended to OD650 nm of 1.0 in 50 mM Tris-HCl (pH 7.6), 2 mM CaCl2,
0.05% Triton X-100. The suspensions were incubated in a 37°C shaking water bath, and the
OD580 nm was monitored for 3 h.
Zymography was used to detect the lytic activities in culture supernatants from Newman
and Newman ΔtagO, as described by Groicher et al. [50]. Overnight culture supernatants, con-
centrated with Centricon-5 centrifugal filter units (Millipore) to a protein concentration of
2.65 mg/ml, were electrophoresed in a 10% polyacrylamide SDS gel supplemented with 1
mg/ml S. aureus cell walls. After washing the gel in 1% Triton X-100 and 25 mM Tris-HCl
buffer overnight to allow cell wall hydrolysis, the gel was stained with 1% methylene blue and
destained in water. Lytic zones in the gel indicated proteins with peptidoglycan hydrolase
activity.
S. aureus autolysin extracts were prepared by 3 M LiCl treatment as described [51]. Peptido-
glycan samples, prepared from strains Newman or Newman ΔtagO as described previously
[22], were suspended in 0.01 M KHPO4 buffer (pH 7.1) to OD580 nm of 0.5 to 0.6. The suspen-
sions were mixed with an S. aureus Newman autolysin extract (25 μg/ml protein), incubated in
a 30°C water bath, and OD580 nm readings were taken at 1 h intervals. Lytic activity was
expressed as a percentage of the OD580 nm at time zero.
Supporting Information
S1 Fig. S. aureus GI colonization is dependent upon the addition of Sm to the drinking
water.Mice received drinking water supplemented with Sm for the entire 3-week period, for
only one week, or not at all. Each dot indicates the CFU S. aureus/g stool for a single mouse,
and the median of each group of animals is indicated by a horizontal line. The lower limit of
detection by culture was 2.5 log CFU/g stool. P-values were determined by Kruskal-Wallis test
with Dunn’s multiple comparison test.  P< 0.05;  P< 0.01.
(TIF)
S2 Fig. An S. aureus clfAmutant showed a competitive defect in colonization of the murine
GI tract following inoculation by oral gavage. The competitive index (CI) was defined as the
log10 output ratio/ input ratio. A CI<0 indicates a mutant with a colonization advantage over
the WT strain, and a CI>0 indicates a mutant with a colonization disadvantage compared to
the WT. Horizontal bars represent the median competitive index for groups of 10 mice. P-val-
ues were determined by the Wilcoxon signed-rank test. P< 0.05;  P< 0.01.
(TIFF)
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S3 Fig. Newman Δica, Newman ΔclfB, Newman Δspa, and Newman ΔsdrCDE showed no
colonization defect.
(TIFF)
S4 Fig. Isogenic mutants lacking the serotype 5 capsule (CP), sortase (SrtA), ClfA, or beta
hemolysin (Hlb) colonized individual groups of mice at levels comparable to those of the
parental strain.
(TIFF)
S5 Fig. S. aureus Newman ΔtagO and Δatl ΔtagO showed impaired GI colonization follow-
ing inoculation by oral gavage with 109 CFU. Fecal pellets were cultured quantitatively at the
indicated time points. Each dot indicates the CFU S. aureus/g stool for a single mouse, and the
median of each group of animals is indicated by a horizontal line. The lower limit of detection
by culture was ~2 log CFU/g stool.
(TIFF)
S6 Fig. A tarM tarS double mutant of S. aureus RN4220, which lacks alpha- and beta-O-
linked GlcNAc modifications of its WTA, shows no defect in GI colonization over a 21 day
time period. The mice were inoculated by oral gavage with 109 CFU of each S. aureus strain,
and fecal pellets were cultured quantitatively at indicated time points. Each dot indicates the
CFU S. aureus/g stool for a single mouse, and the median of each group of animals is indicated
by a horizontal line. The lower limit of detection by culture was ~2.5 log CFU/g stool.
(TIFF)
S7 Fig. Both the WT S. aureus strain Newman and the tagOmutant were killed under low
pH conditions (glycine buffer, pH 3.0–3.6).
(TIF)
S8 Fig. Newman ΔtagO was more sensitive than the parental strain to overnight treatments
with the proteolytic enzymes pepsin and trypsin.
(TIFF)
S9 Fig. Compared to the control S. aureus strain V8, strain Newman was only weakly pro-
teolytic, and no significant differences were observed between the protease activity of cul-
ture supernatants derived from the WT or the ΔtagOmutant.
(TIFF)
S10 Fig. Autolysin extracts from strain Newman and Newman ΔtagO showed similar lytic
activity toward peptidoglycan prepared from the wild type S. aureus strain Lafferty.
(TIFF)
S11 Fig. The NewmanWT and atlmutant both colonized the mouse GI tract, whereas the
ΔtagO and the Δatl ΔtagO double mutant were not recovered from the mouse stools 7 and
14 days after inoculation. Each dot indicates the CFU S. aureus/g stool for a single mouse, and
the median of each group of animals is indicated by a horizontal line. The lower limit of detec-
tion by culture was ~200 CFU/g stool. P-values were determined by Kruskal-Wallis test with
Dunn’s multiple comparison test.  P< 0.05;  P< 0.01.
(TIFF)
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